Media

Media

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY

April 2017

03

HRA Pharma appoints David Wright as Chief Executive Officer

March 2017

14

HRA Pharma Strengthens Board with Experienced Industry Experts

HRA Pharma Announces CEO Transition to Position Company for the Next Phase of Growth

July 2016

12

HRA Pharma Announces CEO Transition to Position Company for the Next Phase of Growth

March 2016

08

A frisky continent: European women’s attitudes to sex and emergency contraception revealed!

Février 2016

19

HRA Pharma Wraps up Landmark 2015 and Announces Investment by Astorg and its co-investor Goldman Sachs Merchant Banking Division to Support Ambitious Growth Plans

May 2015

11

Historic decision grants Italian women direct access to ellaOne® oral emergency contraceptive

April 2015

17

ellaOne® Receives Prestigious Nicholas Hall & Company Award for the Most Innovative European New Product of the Year

HRA Pharma Closes Investment in Embera NeuroTherapeutics to Advance Development of Novel Therapies for Addiction

April 2015

12

HRA Pharma Closes Investment in Embera NeuroTherapeutics to Advance Development of Novel Therapies for Addiction

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?